Impact of splenectomy and immunochemotherapy on survival following gastrectomy for carcinoma: Covariate interaction with immunosuppressive acidic protein, a serum marker for the host immune system

Surgery Today

Volumn 29, Issue 6, 1999, Pages 504-510

  Saji, Shigetoyo ^a   Sakamoto, Junichi ^b   Teramukai, Satoshi ^c   Kunieda, Katsuyuki ^a   Sugiyama, Yasuyuki ^a   Ohashi, Yasuo ^c   Nakazato, Hiroaki ^d  

^a GIFU UNIVERSITY   (Japan)

^b AICHI PREFECTURAL UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d Yokoyama Gastrointestinal Hospital   (Japan)

Author keywords

Clinical trial; Cox's proportional hazards model; Gastric cancer; Immunosuppressive acidic protein; Splenectomy

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; IMMUNOSUPPRESSIVE ACID PROTEIN; KRESTIN; MITOMYCIN C; TUMOR MARKER;

ADULT; ARTICLE; CANCER IMMUNOLOGY; CANCER IMMUNOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GASTRECTOMY; HUMAN; IMMUNE RESPONSE; IMMUNE STATUS; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SPLEEN CELL; SPLENECTOMY; STOMACH CARCINOMA;

EID: 0032970158     PISSN: 09411291     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02482344     Document Type: Article

References (43)

1. 1. The Gastrointestinal Tumor Study Group (1982) Controlled trial of adjuvant chemotherapy following curative resection for gastric cancer. Cancer 49:1116-1122
2. 2. Takahashi M, Fujimoto S, Kobayashi K, Takai M, Endoh F, Ohkubo H (1995) Indication for splenectomy combined with total gastrectomy for gastric cancer: analysis of data on 249, gastric cancer patients. Hepato-Gastroenterol 42:230-233
3. 3. Okajima K, Isozaki H (1995) Splenectomy for treatment of gastric cancer: Japanese experience. World J Surg 19:537-540
4. 4. Yasuna O, Hatayama Y, Yamaura Y (1984) Effects of surgical treatment and adjuvant chemotherapy studied by the depth of penetration in gastric cancer patients undergoing curative gastrectomy. Surgery 95:78-83
5. 5. Billiar TR, West MA, Hyland BJ, Simmons RL (1988) Splenectomy alters Kupffer cell response to endotoxin. Arch Surg 123:327-332
6. 6. King H, Shumacker HB (1952) Splenic studies 1. Susceptibility to infection after splenectomy performed in infancy. Ann Surg 136:239-242
7. 7. Downey EC, Shackford SR, Fridlund PH, Ninnemann JL (1987) Long term depressed immune function in patients splenectomized for trauma. J Trauma 27:601-603
8. 8. Griffith JP, Sue-Ling HM, Martin I, Dixon MF, McMahon MJ, Axon ATR, Johnston D (1995) Preservation of the spleen improves survival after radical surgery for gastric cancer. Gut 36:684-690
9. 9. Miwa T, Takezoe S, Moriya N, Iijima T, Gohchi A, Yamashita H, Kojima K, Ichikawa J, Matsumi A, Okamoto K, Orita K (1983) Effects of combined splenectomy and immunotherapy on survival (in Japanese). J Jpn Soc Cancer Ther 18:1815-1820
10. 10. Honda R, Kobayashi K, Kase H, Sato Y, Yanagita K, Yoshio T (1989) Clinical evaluation of splenectomy for immunological influence in surgery of the gastric cancer (in Japanese). Jpn J Gastroenterol Surg 22:2606-2614
11. 11. Toge T, Kameda A, Kuroi K, Seto Y, Yamada H, Arata S, Tomoda S, Hattori T (1985) Analysis of suppressor cell induction by the spleen in relation to splenectomy in gastric cancer patients (in Japanese). Oncologia 14:146-151
12. 12. Toge T, Hattori T, Orita K, Ishibiki K, Yoshino K, Yamagishi H, Gohchi A, Okamura K, Nose Y, Miwa K, Inokuchi K (1990) Research on the meaning of splenectomy in gastric cancer operation: survival, postoperative complications and changes in immunological parameters (in Japanese). Proc Jpn Soc Cancer Ther 25:271
13. 13. Maehara Y, Moriguchi S, Yoshida M, Takahashi I, Korenaga D, Sugimachi K (1991) Splenectomy does not correlate with length of survival in patients undergoing curative total gastrectomy for gastric carcinoma. Cancer 67:3006-3009
14. 14. Clark JL, Saenz RH, Nava HR, Douglass HO (1991) Impact of splenectomy on survival following gastrectomy for adenocarcinoma. Am Surgeon 57:496-501
15. 15. Nakazato H, Koike A, Saji S, Ogawa N, Sakamoto J (1994) Efficacy of immunochemotherapy as adjuvant treatment after curative resection of gastric cancer. Lancet 343:1122-1126
16. 16. Tamura K, Shibata Y, Matsuda Y, Ishida N (1981) Isolation and characterization of an immunosuppressive acidic protein from ascitic fluids of cancer patients. Cancer Res 41:3244-3252
17. 17. Shibata Y, Tamura K, Ishida N (1983) In vivo analysis of the suppressive effects of immunosuppressive acidic protein, a type of alpha-1 acid glycoprotein, in connection with its high level in tumor-bearing mice. Cancer Res 43:2889-2896
18. 18. Kennedy BJ (1987) The unified international gastric cancer staging classification. Scand J Gastroenterol 22 (suppl 133):11-13
19. 19. Sakamoto J, Teramukai S, Koike A, Saji S, Ohashi Y, Nakazato H (1996) Prognostic value of preoperative immunosuppressive acidic protein in patients with gastric carcinoma: findings from three independent clinical trials. Cancer 77:2206-2212
20. 20. Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 6:371-375
21. 21. Cox DR (1972) Regression models and life tables. J R Statist Soc B 34:187-220
22. 22. Ellison EC, Fabri PJ (1983) Complications of splenectomy. Surg Clin North Am 63:1313-1330
23. 23. Lockwood CM (1983) Immune functions of the spleen. Clin Lab Haematol 12:449-465
24. 24. Llende M, Santiago-Delphin EA, Lavergne J (1986) Immunobiological consequences of splenectomy: a review. J Surg Res 40:85-94
25. 25. Hellstrom I (1970) Serum mediated inhibition of cellular immunity to methylcholanthrene-induced murine sarcomas. Cell Immunol 1:18-30
26. 26. Subramanian C, Mckhann CF (1978) Soluble suppressor factor from the spleens of tumor-bearing mice. Cancer Res 38:1996-2002
27. 27. Cuschieri A, Fayers P, Fielding J, Craven J, Bancewicz J, Joypaul V, Cook P (1996) Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomized controlled surgical trial. Lancet 347:995-999
28. 28. Robertson CS, Chung SCS, Woods SDS, Griffin SM, Raimes SA, Lau JTF, Li AKC (1994) A prospective randomized trial comparing R1 subtotal gastrectomy with R3 total gastrectomy for antral cancer. Ann Surg 220:176-182
29. 29. Standage BA, Gross JC (1982) Outcome and sepsis after splenectomy in adults. Am J Surg 143:545-548
30. 30. Yamagishi H, Pellis NR, Kahan BD (1980) Effect of splenectomy upon tumor growth: characterization of splenic tumor-enhancing cells in vivo. Surgery 87:655-661
31. 31. Saji S, Oshita H, Yamamoto S, Takekoshi T, Sakata K (1983) Experimental study on merits and demerits of splenectomy in tumor bearers. J Surg Oncol 23:35-40
32. 32. Orita K, Konaga E, Okada T, Kunisada K, Yumura M, Tanaka S (1977) Effect of splenectomy in tumor-bearing mice and gastric cancer patients. Gann 68:731-736
33. 33. Nordlund J, Gershon R (1975) Splenic regulation of the clinical appearance of small tumors. J Immunol 114:1486-1490
34. 34. Yashino K, Asanuma K, Haruyama F, Kubochi K, Suzuki K, Inada T, Konno H, Kurihara H, Okusawa S, Kubota T, Kumai K, Ishibiki K, Abe O (1983) Evaluation of splenectomy for possible metastasis from gastric cancer, with reference to nonspecific immunological parameters and postoperative survival. J Jpn Surg Soc 83:947-951
35. 35. Honda R, Kobayashi K, Kato H, Sato Y, Yanagida K, Yoshio T (1989) Clinical evaluation of splenectomy for immunological influence in surgery of the gastric cancer. Jpn J Gastroenterol Surg 22:2606-2614
36. 36. Sugimachi K, Kodama Y, Kumashiro R, Kanematsu T, Noda S, Inokuchi K (1980) Critical evaluation of prophylactic splenectomy in total gastrectomy for the stomach cancer. Gann 71:704-709
37. 37. Suehiro S, Nagasue N, Ogawa Y, Sasaki Y, Hirose S, Yukaya H (1984) The negative effect of splenectomy on the prognosis of gastric cancer. Am J Surg 148:645-648
38. 38. Brady MS, Rogatko A, Dent LL, Shiu MH (1991) Effect of splenectomy on morbidity and survival following curative gastrectomy for carcinoma. Arch Surg 126:359-364
39. 39. Miwa H, Kojima K, Ono F, Kobayashi T, Tsurumi T, Hatosaki A, Iijima T, Orita K (1983) Effect of splenectomy and immunotherapy on advanced gastric cancer associated with total gastrectomy. Jpn J Surg 13:20-24
40. 40. Ogoshi K, Miyaji M, Iwata K, Kondoh Y, Tajima T, Mitomi T (1992) Splenectomy, immunosuppressive acidic protein and post-operative immunotherapy in gastric cancer patients with total or proximal gastrectomy; a multivariate analysis. Ann Cancer Res Ther 1:61-66
41. 41. Shibata Y, Tamura K, Ishida N (1983) In vivo analysis of the suppressive effects of immunosuppressive acidic protein, a type of alpha-1 acid glycoprotein, in connection with the high level in the tumor bearing mice. Cancer Res 43:2889-2896
42. 42. Gahmgerg CG, Anderson LC (1987) Leucocyte surface origin of human alpha-1 acid glycoprotein (orosomucoid). J Exp Med 148:507-521
43. 43. Beutler B, Cerami A. Cachectin and tumor necrosis factors as two sides of the same biological coin. Nature 320:584-588